Idiopátiás tüdőfibrózis: vizsgálatok itt: Lengyelország
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Bialystok, Bydgoszcz, Sosnowiec, Świdnik
- Életkor
- 40 év and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - 2. fázisTaking peopleA Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Lodz, Łódź, Nowa Sol, Rzeszów, Sosnowiec, Warsaw
- Életkor
- 40 év and over
- People
- 120 worldwide
- Run by
- Rein Therapeutics
See details and how to joinNCT06968845 · EU 2025-520715-13-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Bialystok, Cracow, Lodz, Poznan, Rzeszów, Warsaw
- Életkor
- 18 év and over
- People
- 139 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525016-41-00 - 2. fázisTaking peopleAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Where
- Gdansk, Lodz
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT06951217 - 2. fázisNot yet taking people in LengyelországA Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
- Where
- Bydgoszcz, Lodz, Lublin, Olsztyn
- Életkor
- 18 év and over
- People
- 112 worldwide
- Run by
- Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 - 3. fázisNot yet taking people in LengyelországLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Bialystok, Bydgoszcz, Gdansk, Lodz, Olsztyn
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Bialystok, Krakow, Lodz, Poznan, Rzeszów, Warsaw
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - 3. fázisNot yet taking people in LengyelországTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Katowice, Sosnowiec, Szczecin, Warsaw
- Életkor
- 40 év and over
- People
- 1100 worldwide
- Run by
- PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00 - 2. fázisNot yet taking people in LengyelországA Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Where
- Katowice, Lodz, Szczecin, Warsaw
- Életkor
- 40 év and over
- People
- 240 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00 - 2. fázisTaking peopleAn Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
- Where
- Bydgoszcz, Gdansk, Katowice, Lodz
- Életkor
- 18 év and over
- People
- 128 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Bialystok, Bydgoszcz, Gdansk, Katowice, Lodz, Olsztyn
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Bialystok, Bydgoszcz, Gdansk, Katowice, Lodz, Olsztyn
- Életkor
- 18 év and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 - 2. fázisTaking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Bydgoszcz, Sosnowiec, Warsaw
- Életkor
- 40 év and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00